Cell Therapeutics vor Tounaround?
Das wird nichts.
Was soll man nun noch glauben?
Forbes kommentiert es sogar so:
The staffers said that the main trial of the company's drug, pixantrone, may not provide enough evidence to draw firm conclusions about safety or efficacy, and that the drug had both blood-related and cardiac side effects. The FDA also said an agreement it made with Cell Therapeutics that the company's trial would be sufficient for approval was "invalidated" because the trial was stopped early.
http://blogs.forbes.com/sciencebiz/2010/02/...-snow/?partner=yahootix
ICh werde das Gefühl nicht los, das CTIC für das ODAC Meeting noch etwas verschweigt, ob positiv oder negativ?!
Streaming Börsenkurse SindCELL THERAPEUTICS INC NEW( CTIC :NASDAQ)
*Real Time Stock QuoteDaten verzögert sich|Source: NASDAQ Real-time Last Sale
Erweiterte Öffnungszeiten Unavailable
Letzter Kurs 0.114(+17.81%)
Ändern* 5,875,221
Band 09:30:00 AM EST
0.7895
Last Trade 0.1495(+23.36%)
Ändern
* 34,729,297
Band 11:45:09 AM EST
Trade Time